8-K: BioAge Labs Stockholders Elect Directors and Ratify KPMG as Auditor at 2025 Annual Meeting

BioAge Labs, Inc. announced that its stockholders approved the election of three Class I Directors and ratified KPMG LLP as its independent registered public accounting firm for the 2025 fiscal year at its Annual Meeting held on June 5, 2025.

Summary

• BioAge Labs, Inc. held its 2025 Annual Meeting of Stockholders on June 5, 2025.
• Stockholders approved the election of three Class I Directors: Kristen Fortney, Ph.D., Eric Morgen, M.D., and Vijay Pande, Ph.D., each to serve a three-year term expiring at the 2028 Annual Meeting of Stockholders.
• The vote tallies for director elections were: Kristen Fortney (17,302,916 Shares For, 2,080,603 Shares Withheld), Eric Morgen (17,188,188 Shares For, 2,195,331 Shares Withheld), and Vijay Pande (17,219,427 Shares For, 2,164,092 Shares Withheld), with 6,051,187 Broker Non-Votes for each nominee.
• The appointment of KPMG LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025, was ratified by stockholders.
• The ratification vote for KPMG LLP was 25,372,549 Shares For, 55,336 Shares Against, and 6,821 Shares Abstaining.

Sentiment

Score: 7

Explanation: The sentiment is positive as all proposed resolutions, including director elections and auditor ratification, passed successfully with strong stockholder support, indicating stable corporate governance.

Positives

• Successful election of all three proposed Class I Directors, ensuring continuity in board leadership.
• Strong stockholder support for the ratification of KPMG LLP as the independent auditor, indicating confidence in financial oversight and compliance.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding the company's future outlook.

Industry Context

This filing pertains to routine corporate governance matters, specifically the results of an annual stockholder meeting, and does not provide information relevant to broader industry trends or competitive landscape.

Corporate Governance

Stakeholder Impact

• Shareholders: The successful election of directors and ratification of the auditor provides clarity on corporate governance and financial oversight, potentially reinforcing investor confidence.
• Management/Board: The elected directors will continue to provide strategic oversight and guidance to the company's management.

Next Steps

• The elected Class I Directors (Kristen Fortney, Ph.D., Eric Morgen, M.D., and Vijay Pande, Ph.D.) will serve their three-year terms until the 2028 Annual Meeting of Stockholders.
• KPMG LLP will serve as the independent registered public accounting firm for the fiscal year ending December 31, 2025.

Key Dates

Recommendation

Keywords

BioAge Labs, BIOA, 8-K filing, Annual Meeting, Stockholder Vote, Director Election, Corporate Governance, KPMG LLP, Auditor Ratification, SEC filing